Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial

SIMPLE SUMMARY: This is the first report on the clinical use of a new derivative of enrofloxacin (enrofloxacin HCl-2H2O or enro-C) for the treatment of canine unresponsive deep-pyoderma (UDCP), utilizing a dual scheme, i.e., 10 mg/kg/day in capsules, plus the topical administration of enro-C, prepar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Lilia, Tapia, Graciela, Ocampo, Luis, Monroy-Barreto, Minerva, Sumano, Hector
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341524/
https://www.ncbi.nlm.nih.gov/pubmed/32485942
http://dx.doi.org/10.3390/ani10060943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341524/
https://www.ncbi.nlm.nih.gov/pubmed/32485942
http://dx.doi.org/10.3390/ani10060943

Ejemplares similares